XML 23 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   47,369,000    
Beginning balance at Dec. 31, 2023 $ 43,503 $ 5 $ 657,232 $ (613,734)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense 58,518   58,518  
Issuance of shares upon exercise of stock options (in shares)   3,449,000    
Issuance of shares upon exercise of stock options 71,678   71,678  
Issuance of shares upon exercise of warrants (in shares)   2,746,000    
Acquisition of Former Parent’s common stock, stock options, and warrants by the Acquirer (in shares)   (53,564,000)    
Acquisition of Former Parent’s common stock, stock options, and warrants by the Acquirer (1,743,729) $ (5) (563,754) (1,179,970)
Issuance of shares in Distribution (in shares)   14,476,000    
Issuance of shares in Distribution 16,042 $ 1 16,041  
Net income (loss) $ 1,687,572     1,687,572
Ending balance (in shares) at Dec. 31, 2024 14,475,904 14,476,000    
Ending balance at Dec. 31, 2024 $ 133,584 $ 1 239,715 (106,132)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense 11,138   11,138  
Issuance of warrants in connection with 2025 Loan Agreement 1,720   1,720  
Issuance of shares upon exercise of stock options (in shares)   102,000    
Issuance of shares upon exercise of stock options 1,606   1,606  
Net income (loss) $ (140,055)     (140,055)
Ending balance (in shares) at Dec. 31, 2025 14,577,609 14,578,000    
Ending balance at Dec. 31, 2025 $ 7,993 $ 1 $ 254,179 $ (246,187)